Answers are grounded in this paper and cite their sources.
Context: This study investigated the resistance pattern of Shigella sonnei among diarrhoeal patients across selected health facilities in Benue South, Nigeria. There is a rise in antimicrobial resistance in Shigella spp. within resource-limited settings such as Benue South, where antibiotics are often prescribed empirically. Objective: This study aims to investigate the prevalence and antibiotic resistance pattern of Shigella sonnei in stool samples from diarrhoeal patients. Method: Four hundred stool samples were obtained from diarrhoeal patients attending selected health facilities across Benue South. Stool samples were analysed using morphological characteristics, Gram staining, biochemical tests, and Kirby-Bauer disk diffusion methods. Whole-genome sequencing was used to confirm the isolates. Results: The current findings from this study indicated an overall prevalence of 8.3% (95% CI: 5.5-10.9) of Shigella sonnei in sampled healthcare-attending patients. Okpokwu had the highest prevalence of 11.9% (n=400), Obi (6.1%), Otukpo (6.0%) and Apa (5.2%), respectively. Out of 33 confirmed Shigella sonnei isolates, 96% (32) were resistant to one or more classes of antibiotics, with ciprofloxacin, Amoxicillin-clavulanic acid and ceftriaxone recording 48.4% resistance, respectively. Gentamicin had the lowest resistance rate of 27.2%. None of the isolates was resistant to imipenem. Furthermore, there is a clustering of multidrug-resistant isolates in Okpokwu (57.9%) and Otukpo (50.0%), accounting for all 14 multidrug-resistant cases. Conclusion: High resistance to recommended antibiotics has been reported in this study. Further investigation of the resistance and virulence genes is vital for enhanced surveillance data.
No takes yet. Share an insight, caveat, or question.
David et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: